EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era
Stef Schutte
02 Dec, 2025
With 30+ years in pharma, Stef has led global Regulatory Affairs at Astellas and served as Head of RA-EMEA at Merck (MSD), advancing development, approvals, and compliance across international markets.
Extensive experience in strengthening regulatory operations, accelerating product development pathways, and building high-performing teams.
Other Related Articles
26 Mar, 2026
18 Mar, 2026
10 Mar, 2026
24 Feb, 2026
